US Corporate Distress Financial Stress SEC Filings — March 17, 2026

17-03-2026

American Rebel Holdings Inc entered into a Securities Purchase Agreement issuing a promissory note to 1800 Diagonal Lending LLC with a principal amount of $124,200 purchased for $108,000 (including $16,200 OID), requiring total repayments of $147,487 over 15 monthly installments from April 15, 2026 to June 15, 2027 at an effective 15% interest rate. The note includes high default interest of 22%, acceleration to 150% of outstanding amounts upon events of default, and conversion rights into common stock (limited to 4.99% beneficial ownership, subject to Nasdaq 19.99% rule without stockholder approval), posing dilution risk. Prepayment is permitted at 95% of principal plus interest within the first 180 days without penalty.

• ·5-day grace period for payments; missed payment triggers Event of Default.
• ·Covenant restricts sale of significant assets without Holder consent to avoid shell company status.
• ·Events of Default include failure to pay (after 5 business days notice), covenant breaches (after 20 days notice), bankruptcy, delisting from Exchanges, non-compliance with Exchange Act reporting.
• ·Conversion rights exercisable only after Event of Default; Notice of Conversion must be before 6pm NY time.
• ·Prepayment requires 3 Trading Days prior notice; no partial prepayments except as specified.

17-03-2026

Tenon Medical, Inc. closed a private placement of senior convertible promissory notes with institutional and high net worth investors for gross proceeds of $4.3 million before placement agent fees. The notes have a 20% original issue discount, aggregate principal of $4.3 million, mature on September 11, 2026, and are convertible into common stock after a six-month anniversary at 80% of the VWAP for the prior three trading days. Net proceeds will support commercial expansion, product development, clinical studies, working capital, and general corporate purposes.

• ·Notes not registered under Securities Act of 1933; may not be offered or sold absent registration or exemption
• ·WallachBeth Capital, Inc. acted as placement agent
• ·National launch of Catamaran SI Joint Fusion System in October 2022
• ·Company formed in 2012

17-03-2026

Integrated Rail & Resources Inc. entered into a Securities Purchase Agreement on March 9, 2026, with B H, Inc., issuing 7,056 shares of Series A Convertible Preferred Stock to fully settle $705,589 in remaining outstanding debt, following a $750,000 cash payment on February 18, 2026, against an original $1,455,589 debt as of February 17, 2026. The Buyer joined the existing Registration Rights Agreement and released all claims related to the debt. The issuance relied on exemptions under Section 4(a)(2) and Rule 506 of Regulation D, with no cash consideration received by the Company.

• ·Debt originated from specific invoices: #200653 ($449,581, Dec 16, 2024), #205275 ($190,548, Jul 31, 2025), #205881 ($444,600, Sep 2, 2025), #206576 ($105,860, Sep 30, 2025), #207152 ($125,000, Oct 28, 2025), #208792 ($140,000, Jan 27, 2026)
• ·Preferred Shares have par value of $0.0001 per share
• ·Stifel, Nicolaus & Co. acted as advisor to the Company

17-03-2026

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing CNS cancer therapies, appointed David Choi as Chief Accounting Officer effective March 13, 2026, to oversee accounting, financial reporting, internal controls, and governance as it advances Phase II trials. Mr. Choi brings over a decade of experience from Blythe Global Advisors, Grant Thornton, and Ernst & Young, including SEC reporting and SOX compliance. The appointment supports the company's growth with its NEO™ platform, including NEO100™ and NEO212™ under FDA Fast-Track status.

• ·Patent protections extending to 2038.
• ·Exclusively licensed worldwide patent portfolio from University of Southern California for NEO100, NEO212, and related products.
• ·Risk factors referenced in 10-Q for three months ended March 31, 2025.

17-03-2026

Clene Inc. entered into a third-year subaward agreement with New York University on March 13, 2026, for up to $8.0 million under the four-year $45.1 million NIH Grant, supporting the Expanded Access Program for CNM-Au8® treatment of amyotrophic lateral sclerosis from September 1, 2025, to August 31, 2026. This follows prior subawards of $7.3 million for Year 1 (September 2023-August 2024) with Columbia University and $8.0 million for Year 2 (September 2024-August 2025). Funds are reimbursable via monthly invoices, with either party able to terminate on 30 days' notice.

• ·Disbursement based on monthly invoices for reimbursement to Clene Nanomedicine, Inc.
• ·Company retains all rights to Background IP developed at private expense; no licenses granted to NYU or U.S. Government.
• ·Either party may terminate with 30 days' written notice.

17-03-2026

Indivior Pharmaceuticals, Inc. issued $500M principal amount of 0.625% Convertible Senior Notes due 2031 on March 17, 2026, including $50M from the full exercise of the initial purchasers' option, providing low-cost financing at 0.625% interest payable semi-annually starting September 15, 2026. Proceeds were used to fully prepay and terminate a prior Note Purchase Agreement dated November 4, 2024 (amended January 26, 2026). The notes introduce potential equity dilution from up to 16.2M shares issuable upon conversion at an initial rate of 24.0033 shares per $1,000 principal (35% premium over March 12, 2026 closing price).

• ·Notes mature March 15, 2031; convertible starting December 16, 2030 at any time, earlier upon certain events.
• ·Redemption possible on or after March 20, 2029 if stock price exceeds 130% of conversion price for specified periods.
• ·Fundamental Change repurchase right at principal plus accrued interest.
• ·Events of Default include payment defaults, covenant breaches, and acceleration of $55M+ indebtedness.

17-03-2026

Urgent.ly Inc. failed to regain compliance with Nasdaq Listing Rule 5550(b) by the March 16, 2026 deadline due to insufficient net income, resulting in trading suspension of its common stock (ULY) at the open on March 18, 2026, and delisting effective 10 days after Nasdaq files Form 25. However, the company entered a Merger Agreement with Agero, Inc. on March 13, 2026, involving a cash tender offer, and plans to transition trading to OTCQB Venture Market, though with no assurance of volumes or prices. The delisting is not expected to impact business operations, and the company will remain a reporting entity under the Exchange Act until the merger closes.

• ·Nasdaq notified of noncompliance previously; appeal hearing stayed delisting until March 16, 2026 compliance deadline.
• ·Company confirmed Merger Agreement to Nasdaq on March 16, 2026, but did not regain compliance.
• ·Tender offer by Agero not yet commenced; Schedule TO and 14D-9 to be filed with SEC.
• ·References prior SEC filings: Form 10-K for FY ended Dec 31, 2024 (filed Mar 14, 2025, amended Apr 17, 2025).

17-03-2026

Frontier Airlines, a subsidiary of Frontier Group Holdings, Inc., entered Amendment No. 20 with Airbus S.A.S. deferring delivery of 69 A320neo family aircraft from 2027-2030 to 2031-2033, providing potential liquidity relief. Separately, it signed an Early Return Agreement with AerCap Holdings N.V. to terminate leases on 24 operating A320neo aircraft, reducing $400M in lease assets and liabilities, but expecting $125-175M in non-cash charges and $75-95M in cash charges in Q1/Q2 2026. AerCap also committed to 10 future sale-leaseback transactions for 2028-2029 deliveries.

• ·Leases for the 24 A320neo aircraft were originally scheduled to expire in 2-8 years.
• ·Non-cash charges primarily from write-off of prepaid maintenance and accelerated depreciation.
• ·Cash charges largely settled in 2028-2029.

17-03-2026

Orion Group Holdings, Inc. announced the retirements of independent board members Thomas N. Amonett (serving since 2007) and Margaret M. Foran (serving since 2019), effective at the Annual General Meeting on May 19, 2026, with the Board size decreasing from eight to six directors. Chairman Austin Shanfelter thanked them for their leadership contributions, including committee chairs, and expressed confidence in the Company's future positioning. Both retiring members highlighted their pride in the Company's transformation and strong management team.

• ·Filing date: March 17, 2026
• ·Annual General Meeting of Stockholders: May 19, 2026
• ·Company headquartered in Houston, Texas
• ·Contact: Margaret Boyce, 346-278-3762, mboyce@orn.net

17-03-2026

TaskUs, Inc. (via subsidiary TU Bidco, Inc.) entered into a Second Amended and Restated Credit Agreement on March 11, 2026, establishing $500M in Restatement Date Term Loans and a $100M Revolving Credit Facility. Proceeds from the Term Loans will refinance all existing Term Loans and Revolving Loans under the prior agreement (dated September 7, 2022), fund a Restatement Date Distribution, and cover related fees and expenses. Existing Letters of Credit continue under the new agreement, with Revolving Facility proceeds available for working capital and general corporate purposes including permitted acquisitions.

• ·Original Credit Agreement dated September 25, 2019, amended April 30, 2021, and restated September 7, 2022.
• ·SEC 8-K filed March 17, 2026, covering Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits).

17-03-2026

Aterian, Inc. entered into Amendment No. 5 to its Credit and Security Agreement on March 13, 2026, reducing the Minimum Credit Party Liquidity covenant to $3.5 million effective through April 12, 2026. The reduction can be extended weekly at the company's option through May 9, 2026, subject to compliance with fee payment obligations. This amendment provides temporary covenant relief amid potential liquidity constraints.

• ·Original Credit and Security Agreement dated December 22, 2021
• ·Amendment filed on March 17, 2026

17-03-2026

Beazer Homes USA, Inc. entered into a third amendment to its senior unsecured revolving credit facility, increasing the aggregate commitment from $365M to $525M (a 43.8% expansion) and extending the maturity from March 15, 2028, to March 13, 2030. The amendment, arranged by JP Morgan Chase Bank, N.A., Royal Bank of Canada, Truist Securities, Inc., and Regions Capital Markets, enhances liquidity and financial flexibility to support multi-year goals for community growth, de-leveraging, and book value per share increase, per CFO David Goldberg. No declines or flat metrics reported in facility terms.

• ·Beazer Homes builds in 13 states nationwide.
• ·Headquartered in Atlanta, Georgia.

17-03-2026

DTE Electric Company, a subsidiary of DTE Energy Company, entered into a Primary Supply Agreement (PSA) and Clean Capacity Accelerator Agreement (CCAA) with Google LLC on March 16, 2026, to provide electric service to Google's future 1.0 gigawatt data center in southeast Michigan through December 2047. Under the CCAA, DTE Electric will deploy up to 480 megawatts of energy storage and 1,600 megawatts of renewable generation over a 20-year term, supported by approximately 300 megawatts of Zonal Resource Credits from Google at no cost. The agreements include minimum monthly charges, potential termination fees, and credit support from Alphabet Inc., with full details to be filed in the Q1 2026 10-Q.

• ·PSA term runs through December 2047 with extension options
• ·CCAA 20-year term with mutual extension options
• ·Data center located in southeast Michigan
• ·Customer's parent (Alphabet Inc.) provides credit support for both agreements
• ·Agreements to be fully filed in Form 10-Q for quarter ending March 31, 2026

17-03-2026

Cyngn Inc. (NASDAQ: CYN) announced a $9.65M registered direct offering of 5,000,000 shares of Common Stock (or pre-funded warrants) priced at $1.93 per share under Nasdaq rules, with a single institutional investor acquiring over 90% and a high-net-worth individual the remainder. Gross proceeds are expected from the offering closing on or about March 17, 2026, to be used for general corporate purposes and working capital, resulting in approximately 16,896,493 shares outstanding post-closing assuming full exercise of pre-funded warrants. No prior share count or performance comparisons were provided in the filing.

• ·Shelf registration statement on Form S-3 (No. 333-290079) effective September 18, 2025.
• ·Annual report on Form 10-K filed with SEC on November 14, 2025.
• ·Pre-funded warrants exercisable immediately at $0.00001 per share.

17-03-2026

On March 13, 2026, Fractyl Health, Inc. received a notice from Nasdaq for failing to satisfy Listing Rule 5450(a)(1), as its common stock (GUTS) bid price was below $1.00 for 30 consecutive business days, with no immediate impact on current listing. The company has 180 calendar days until September 9, 2026, to regain compliance by closing at $1.00 or higher for 10 consecutive business days, or face potential transfer to Nasdaq Capital Market or delisting. Fractyl intends to monitor the issue and consider options like a reverse stock split, but success is not assured.

• ·Emerging growth company status: Yes.
• ·Current listing: The Nasdaq Global Market.
• ·Par value of common stock: $0.00001 per share.

17-03-2026

Duos Technologies Group, through Duos Edge AI, executed a definitive GPUaaS contract with Hydra Host expected to generate $176M in revenue over 36 months, $50M+ in annual revenue, $40M+ in annual EBITDA, and gross margins exceeding 80%, supported by an initial $18M customer prepayment. The agreement includes a 4.3MW high-power EDC deployment for a leading global tech company as anchor tenant, funded by the company's recent $65M public offering. This deal validates the High-Power EDC model, with additional sites under evaluation toward a 75MW long-term capacity goal.

• ·Manufacturing of EDCs underway with critical power modules ordered.
• ·CEO Doug Recker appointment effective April 1, 2026.
• ·Additional high-density power sites under active evaluation.

17-03-2026

Akari Therapeutics, Plc announced a change in the ratio of its American Depositary Shares (ADSs) from one ADS representing 2,000 Ordinary Shares to one ADS representing 80,000 Ordinary Shares, resulting in a one-for-forty reverse split of issued and outstanding ADSs, effective on or about March 31, 2026. This Ratio Change will have no effect on the Ordinary Shares themselves but is intended to potentially help meet Nasdaq's minimum bid price requirement, with no assurance of success. The announcement was issued via press release on March 17, 2026.

• ·Ratio Change effective on or about March 31, 2026.
• ·Trading symbol AKTX remains unchanged.
• ·Information in Item 7.01 and Exhibit 99.1 is furnished, not filed.

17-03-2026

Curis, Inc. filed an 8-K on March 17, 2026, including Exhibit 3.1, a Restated Certificate of Incorporation from 2000 and subsequent amendments in 2013 and 2018 to increase authorized capital stock from 130 million total shares (125M common stock, 5M preferred stock) to 230 million total shares (225M common stock, 5M preferred stock). These changes were approved by the Board of Directors and stockholders in accordance with Delaware law. No financial performance metrics, period-over-period comparisons, or operational data are provided.

• ·Par value of $0.01 per share for both Common Stock and Preferred Stock.
• ·Original Certificate of Incorporation filed February 14, 2000.
• ·2013 amendment executed May 30, 2013.
• ·2018 amendment filed May 15, 2018.
• ·Registered office: 1209 Orange Street, Wilmington, Delaware 19801.

17-03-2026

VisionWave Holdings, Inc.'s (VWAV) wholly owned subsidiary SolarDrone Ltd. acquired a 51% controlling interest in Junko Solar Ltd., an Israeli solar panel maintenance company, for total consideration of $204,000 at an agreed valuation of $400,000, structured in three staged payments. The deal includes integrating Junko Solar's operations into SolarDrone and appointing Amos Cohen, Junko's founder, as CEO and Director of SolarDrone. This represents a strategic expansion into the growing solar infrastructure services market.

• ·Transaction structured in three staged payments
• ·Junko Solar specializes in solar panel cleaning and maintenance services to improve efficiency

17-03-2026

Calumet, Inc., through its subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp., completed a private placement of $150 million aggregate principal amount of additional 9.75% Senior Notes due 2031, issued at 105% of par for net proceeds of approximately $154.9 million, to be used to repay outstanding borrowings under its revolving credit facility. This follows the $405 million issuance of Existing Notes on January 12, 2026, with the Additional Notes forming a single series. The CFO cited strong 2025 financial and operational performance, ongoing cash flow generation, and plans to reduce 2028 notes when the call premium steps down in July.

• ·Notes issued under Rule 144A and Regulation S of the Securities Act of 1933.
• ·Accrued interest from January 12, 2026.
• ·Headquartered in Indianapolis, Indiana; operates twelve facilities in North America.

17-03-2026

PAR Technology Corporation announced a proposed private offering of $225.0 million aggregate principal amount of Convertible Senior Notes due 2031 to qualified institutional buyers, with an option for the initial purchaser to buy up to an additional $25.0 million. The company intends to use net proceeds to repurchase a portion of its 1.50% Convertible Senior Notes due 2027, repurchase up to $40 million of common stock, and for general corporate purposes including potential acquisitions. Concurrently, J. Wood Capital Advisors LLC plans to purchase up to $10 million of common stock at a discount.

• ·Notes not redeemable prior to March 20, 2029; convertible under certain circumstances prior to that date.
• ·Redemption possible on or after March 20, 2029, if common stock price >=130% of conversion price for specified period.
• ·Offering subject to market conditions; interest rate and conversion rate to be determined at pricing.

17-03-2026

Reliance Global Group, Inc. (RELIW) filed an 8-K on March 17, 2026, disclosing entry into a material definitive agreement (Item 1.01) and amendments to its articles of incorporation or bylaws (Item 5.03). Exhibit 3.1 was attached as part of Item 9.01. No specific financial impacts or quantitative details were provided in the filing content.

• ·Filing includes Items 1.01 (Material Definitive Agreement), 5.03 (Amendments to Articles/Bylaws), and 9.01 (Exhibits)

17-03-2026

On March 13, 2026, Ashford Hospitality Trust, Inc. entered into a Limited Waiver under its Third Amended and Restated Advisory Agreement with Ashford Hospitality Limited Partnership, Ashford TRS Corporation, Ashford Inc., and Ashford Hospitality Advisors LLC, permitting cash incentive compensation awards to Advisor employees during Q1 and Q2 2026 at the Company's expense. The Company also adopted a Form of Deferred Cash Award. No specific financial amounts or performance metrics were disclosed.

• ·Advisory Agreement originally dated March 12, 2024
• ·Waiver Period: first and second fiscal quarters of calendar year 2026
• ·Filing signed by Jim Plohg on March 17, 2026

17-03-2026

On March 13, 2026, Braemar Hotels & Resorts Inc. entered into a Limited Waiver under its Fifth Amended and Restated Advisory Agreement with Braemar Hospitality Limited Partnership, Braemar TRS Corporation, Ashford Inc., and Ashford Hospitality Advisors LLC, permitting the Company to award cash incentive compensation to Advisor employees during the first and second fiscal quarters of 2026 at its own expense. The Company also adopted two Forms of Deferred Cash Award on the same date. No financial impacts or performance metrics were disclosed.

• ·Advisory Agreement originally dated April 23, 2018
• ·Limited Waiver attached as Exhibit 10.2
• ·Forms of Deferred Cash Award attached as Exhibits 10.3 and 10.4
• ·Filing submitted on March 17, 2026

17-03-2026

Bluejay Diagnostics, Inc. entered into a securities purchase agreement on March 14, 2026, issuing and selling 62,500 shares of common stock at $2.00 per share to five insiders—CEO Neil Dey, Board Chair Donald Chase, and board members Svetlana Dey, Douglas Wurth, and Fred Zeidman—for aggregate gross proceeds of $125,000. The private placement closed on March 17, 2026, conducted pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, with no registration rights provided. Each purchaser acquired 12,500 shares individually.

• ·Shares have par value of $0.0001 per share.
• ·Transaction not registered under Securities Act; purchasers confirmed as accredited investors with no distribution plans.
• ·No registration rights agreed upon for the securities.

17-03-2026

Jacobs Solutions Inc. and certain subsidiaries entered into a new multicurrency revolving Credit Agreement dated March 16, 2026, with Bank of America, N.A. as Administrative Agent, Swing Line Lender, and L/C Issuer, supported by co-syndication agents BNP Paribas and Wells Fargo, co-documentation agents including The Toronto-Dominion Bank and HSBC, and joint lead arrangers. The facility provides for committed loans, letters of credit, swing line loans in USD, and extensions in alternative currencies such as Euro, Sterling, Australian Dollars, and others, with a companion 2026 Term Loan Agreement referenced. No commitment amounts or specific financial terms were detailed in the filing excerpt.

• ·Filing Type: 8-K dated March 17, 2026 covering Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits)
• ·Deal CUSIP: 46982HAA5; Revolver CUSIP: 46982HAB3
• ·Alternative Currencies include Euro, Sterling, Australian Dollars, Singapore Dollars, Swedish Krona, Canadian Dollars, and other approved Eligible Currencies

17-03-2026

HCW Biologics Inc. (HCWB) closed an exclusive worldwide license for HCW11-006 with Beijing Trimmune Biotech Co., Ltd., receiving a $7.0M upfront fee ($3.5M cash + $3.5M equity). Trimmune, backed by WY Biotech, CITIC Medical Fund, and TigerYeah Capital, will initiate Phase 1 in China in H1 2027 at its cost, with HCW eligible for milestones, double-digit royalties, and a free option to reclaim Americas rights post-Phase 1. No negative financial impacts noted, though forward-looking risks include clinical trial success.

• ·Trimmune has option to license exclusive China rights for HCW9302, with additional payments to HCW if exercised.
• ·HCW9302 Phase 1 study in alopecia areata initiated November 2025 (NCT07049328).
• ·10-K filed with SEC on November 14, 2025.

17-03-2026

Incannex Healthcare Inc. received notification from Nasdaq on March 16, 2026, confirming it has cured its prior bid price deficiency under Listing Rule 5550(a)(2), with common stock maintaining a $1.00 closing bid price for 11 consecutive business days from February 27 through March 13, 2026. The company reports approximately $75M in cash and no debt, positioning it to advance clinical programs like IHL-42X (positive Phase 2 for obstructive sleep apnea) and PSX-001 (positive outcomes for generalized anxiety disorder). This compliance resolves overhangs from prior 8-K filings on April 23, 2025, and October 21, 2025.

• ·Nasdaq Listing Rule 5550(a)(2) compliance regained
• ·Previous deficiency notifications in 8-K filings dated April 23, 2025 and October 21, 2025
• ·Fiscal year end: June 30

17-03-2026

LENSAR, Inc. announced the mutual termination of its merger agreement with Alcon Research, LLC due to the Federal Trade Commission's intent to block the deal, making regulatory approval unlikely by the April 23, 2026 outside date or extended July 23, 2026 date. While disappointed, the company will retain a $10.0 million deposit and remains committed to growing its ALLY Robotic Cataract Laser System, with Q4 and full-year 2025 financial results and strategic update scheduled for March 31, 2026. The termination introduces risks including transaction costs potentially exceeding the deposit, management distraction, and potential litigation or customer retention issues.

• ·Merger outside date: April 23, 2026 (potential extension to July 23, 2026)
• ·Q4 and full-year 2025 financial results conference call: March 31, 2026 at 8:30 a.m. Eastern Time
• ·Risks include transaction costs exceeding retained deposit, litigation, and impacts on customer/supplier relationships

17-03-2026

Tianci International, Inc. (CIIT) filed an 8-K announcing an amendment to its Articles of Incorporation for a 1-for-7 reverse stock split, effective March 20, 2026, at 12:01 a.m. EDT. Under the split, every seven shares of common stock ($0.0001 par value) will be combined into one fully paid, non-assessable share, with no fractional shares issued—instead, fractions are rounded up to the next whole share—and par value remaining unchanged at $0.0001 per share.

• ·Filing date: March 17, 2026
• ·8-K Items reported: 3.03, 5.03, 7.01, 9.01
• ·Old certificates will represent the adjusted number of post-split shares

17-03-2026

Longevity Health Holdings, Inc. (OTCQB: XAGE) appointed Ram Ajjarapu as Chairman and Chief Executive Officer effective March 16, 2026, coinciding with his strategic investment through a private placement that acquired a significant equity position to align interests with shareholders. The leadership change supports an acquisition-focused growth strategy, with outgoing CEO Rajiv Shukla transitioning to an advisory role while remaining a significant shareholder. No financial metrics or performance data were disclosed.

• ·Appointment and private placement closed on March 16, 2026; announcement on March 17, 2026.
• ·Longevity focuses on bio-aesthetics for longevity and healthy aging, selling via B2B, DTC, and distributor channels in the US.

17-03-2026

i-80 Gold Corp. closed a $250M royalty financing with Franco-Nevada, receiving $225M upfront in exchange for a 1.5% LOM NSR royalty (stepping up to 3.0% on January 1, 2031) on all mineral properties, using $165M to retire legacy debts including $73M cash for 2027 Convertible Debentures ($65M principal + $5.3M interest) and $92M to Orion ($50M principal + $20M interest + Gold Prepay). The transaction strengthens the balance sheet and funds advancement of Mineral Point ($50M dedicated) and Archimedes projects, with $25M additional funding available later upon conditions. Approximately 11.1M common shares were issued as part of the debt settlements.

• ·Silver Purchase and Sale Agreement with Orion remains in place.
• ·Pre-feasibility study for Mineral Point anticipated for completion in 2027.
• ·4% premium applied to principal and accrued interest for early mandatory redemption of debentures.

17-03-2026

CNBX Pharmaceuticals Inc. executed a non-convertible promissory note for $45,000 with 3i L.P. on March 10, 2026. The note matures on July 1, 2026, and accrues simple interest at 5% per annum, with proceeds designated for working capital and expenditures. No financial performance metrics or period-over-period comparisons are reported.

• ·Filing signed on March 17, 2026
• ·Registrant is an emerging growth company

17-03-2026

On March 13, 2026, Agassi Sports Entertainment Corp. entered into subscription agreements with two accredited investors, issuing 80,000 shares of restricted common stock at $5.00 per share for total proceeds of $400,000. The Boreta Lifetime Trust, with trustee Ronald S. Boreta (President, CEO, and director), acquired 50,000 shares for $250,000, representing the majority of the placement. The issuance qualifies for exemption under Section 4(a)(2) and Rule 506 of Regulation D, with no sales commissions paid.

• ·Shares issued without general solicitation and to accredited investors only.
• ·Securities not registered under the Securities Act and restricted from resale without exemption.

17-03-2026

Public Storage entered into an Election and Support Agreement dated March 16, 2026, with certain holders of National Storage Affiliates Trust common stock and NSA OP, LP partnership OP units to support its acquisition via mergers under a concurrent Merger Agreement. The holders commit to vote in favor of the mergers, approve related proposals, oppose alternative acquisition proposals, and refrain from transferring subject securities except for permitted transfers until the expiration time. No financial terms or metrics are disclosed in the agreement.

17-03-2026

National Storage Affiliates Trust (NSA) and its operating partnership NSA OP, LP entered into a definitive Agreement and Plan of Merger dated March 16, 2026, with Public Storage and its affiliates, including Public Storage OP, L.P., Pelican Merger Sub I, LLC, and Pelican Merger Sub II, LLC, for Public Storage to acquire NSA via a two-step merger process. The Company Merger will merge NSA into Merger Sub I (with Merger Sub I surviving as a wholly owned subsidiary of Public Storage), followed by the Partnership Merger of Merger Sub II into NSA OP (with NSA OP surviving as an indirect subsidiary), including intermediate steps such as Dropdown JV Contribution, Dropdown JV Financing, and Special Redemption. Both boards have approved the transaction, which is intended to qualify as a tax-free reorganization, with no financial metrics or declines disclosed in the filing.

• ·Agreement executed on March 16, 2026; SEC 8-K filed March 17, 2026
• ·Mergers governed by Maryland REIT Law, Maryland LLC Act, and Delaware Revised Uniform Limited Partnership Act
• ·Company Board and Parent Board declared mergers advisable and in best interests of shareholders/partners
• ·Intended U.S. federal tax treatment: Company Merger as reorganization under IRC Section 368(a); Partnership Merger as 'assets over' under IRC Section 708

17-03-2026

Pono Capital Four, Inc., a blank check SPAC primarily targeting disruptive technology sector businesses, announced the pricing of its $120M initial public offering of 12,000,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one right to one-fifth of a share upon business combination. Units are expected to begin trading on Nasdaq under PONOU on March 13, 2026, with separate trading of shares (PONO) and rights (PONOR) thereafter, and closing anticipated on March 16, 2026 subject to conditions. D. Boral Capital LLC serves as sole book-running manager with a 45-day option for up to 1,800,000 additional units.

• ·SEC registration statement declared effective on March 12, 2026.
• ·Company formed as Cayman Islands exempted company focused on merger, amalgamation, or similar business combination primarily in disruptive technology sector.
• ·Underwriter contact: D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022.

17-03-2026

New Fortress Energy Inc. (NFE) entered a Restructuring Support Agreement (RSA) with creditors for a UK Restructuring Plan, splitting into private BrazilCo (Brazil assets owned by creditors) and public New NFE (remaining assets), reducing New NFE corporate debt from ~$5.7B to ~$527.5M while issuing up to $2.5B preferred equity and 65% common equity to creditors. Existing shareholders will be diluted to 35% of New NFE common equity, with potential further dilution if preferred equity converts after three years. The process launches in April 2026 and is expected to close by Q3 2026, subject to approvals.

• ·Preferred equity PIK coupon: 3% year one, 5% year two, 7% year three; prepayable without penalty.
• ·Early consent fee for RSA accession by March 31, 2026: 0.75% of principal, payable in kind.
• ·UK RP process launch: April 2026.

17-03-2026

HNO International, Inc., a metal mining company, filed an 8-K on March 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. The filing lacks specific financial details or quantitative impacts. This occurs amid a pattern of delayed filings, including an NT 10-Q on the same date indicating ongoing reporting delays.

• ·Company CIK: 0001342916; SIC: 1000 (Metal Mining); Incorporated in NV, based in CA; Fiscal year end: October 31.
• ·Former names: American Bonanza Resources Corp. (through 2009-03-23), Clenergen Corp (through 2019-08-20).